[1] SHEN XM, WANG WP.Pediatrics(儿科学)[M]. 7th ed. Beijing: People's Medical Publishing House, 2011: 3. [2] National Center for ADR Monitoring. WHO adverse reaction terminology (WHO 药品不良反应术语集)[M]. Beijing: China Medical Science and Technology Press, 2003. [3] ZHANG LL, SONG HT.Retrospective analysis on 328 adverse drug reaction reports from department of pediatrics in a grade 3 and first-class hospital from 2013 to 2017[J]. Chinese Journal of Drug Application and Monitoring(中国药物应用与监测), 2019, 16(1): 32-35. [4] PAN WW, NI SQ, LI CM, et al. A s urvey of public perception on clinical research in children[J]. Chinese Journal of Hospital Administration(中华医院管理杂志), 2017, 33(1): 75-78. [5] XIA MQ, BI J, ZHANG YF.Pharmaceutical care for one pediatric patient with drug hypersensitivity syndrome[J]. Journal of Pediatric Pharmacy(儿科药学杂志), 2018, 24(7): 39-42. [6] LIU C, XU HM, TAN LP, et al.Clinical analysis of drug hypersen-sitivity syndrome in 22 children[J]. J Clin Pediatric(临床儿科杂志), 2017, 35(7): 522-524. [7] KAMIJIMA M, WANG H, YAMANOSHITA O, et al.Occupational trichlor-oethylene hypersensitivity syndrome: human herpesvirus 6 reactivation and rash phenotypes[J]. J Dermatol Sci, 2013, 72(3): 218-224. [8] UNO H, KABASHIMA K, TOHYAMA M, et al.TNF-α as a useful predictor of human herpesvirus-6 reactivation and indicator of the disease process in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS)[J].J Dermatol Sci, 2014, 74(2): 177-179. [9] OGAWA K, MORITO H, HASEGAWA A, et al.Elevated serum thymus and activation-regulated chemokine (TARC/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS)[J]. Br J Dermatol, 2014, 171(2): 425-427. [10] TANG XY, LI Y, MA K, et al.Clinical analysis of drug-induced hypersensitivity syndrome in 26 children[J]. Chin J Derma Venereol(中国皮肤性病学杂志), 2019, 33(6): 679-693. [11] HUA X, LIU HJ, ZHANG M, et al.Clinical analysis of 55 cases of drug reaction with eosinophilia and systemic symptoms[J].Chin J Derma Venereol(中国皮肤性病学杂志), 2015, 29(3): 262-264. [12] SHIOHARA T, KANO Y.Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and manag-ement[J]. Expert Opin Drug Saf, 2017, 16(2): 139-147. [13] KARDAUN SH, SIDOROFF A, VALEYRIE-ALLANORE L, et al.Variability inthec-linical pattern of cutaneous side effects of drugs with systemic symptoms: does a DRESS syndrome really exist?[J]. Br J Dermatol, 2007, 156(3) : 609-611. [14] CRIADO PR, CRIADO RF, AVANCINI JM, et al.Drug reaction with eosinophilia and systemic symptoms (DRESS) / drug-induced hypersensitivity syndrome (DIHS): a review of current concepts[J]. An Bras Dermatol, 2012, 87(3) : 435-449. [15] CHIOU CC, YANG LC, HUNG SI, et al.Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan[J]. J Eur A Card Dermatol Venereol, 2008, 22(9) : 1044-1049. [16] MARTINEZ-RODRIGUEZ JE, BARRIGA FJ, SANTAMARIA J, et al.Noncon-vulsive status epflepticus associated with cephalosporins in patients with renal failure[J]. Am J Med, 2001, 111(2): l15-l19. [17] YANG J, LIU LH, YANG H.Two cases of epilepsy form seizure caused by cefoperazone sodium and sulbactam sodium[J]. Journal of Clinical Pharmacotherapy(临床药物治疗杂志), 2017, 15(12): 49-50, 54. [18] ZHANG JA, WANG HL, GUO JP, et al.One case of epilepsy induced by Cefoperazone/sulbactam[J]. China Pharmacist(中国药师), 2011, 14(11): 1664-1665. [19] YANG JZ, XIONG JH, CHEN DW, et al.Analysis of influence factors of adverse reactions of the nervous ssystem caused by cefoperazone/ sulbactam[J]. Chin J Pharmacoepidemiol(药物流行病学杂志), 2016, 25(9): 563-567. [20] WALLACE KL.Antibiotic-induced convulsions[J]. Crit Care Clin, 1997, 13(4): 741-762. [21] FAN QE, YE F, LYU GH, et al.One case of epilepsy induced by cefoperazone and sulbactam[J]. China Pharmacist(中国药师), 2018, 21(10): 1819-1820. [22] SCHÄFER H, NABER K, ADAM D. Hemostasis disturbance caused by cephalosporins with an N-methylthiotetrazole side chain: a randomized pilot study[J]. Arzneimittel-forschung, 1989, 39(9): 1156-1162. [23] SHEARER MJ, BECHTOLD H, ANDRASSY K, et al.Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status[J]. J Clin Pharmacol, 1988, 28(1): 88-95. [24] ZHANG LL, MA LY, CHEN CY, et al.Case report analysis of thrombocytopenia induced by cefoperazone sodium/sulbactam sodium in patient with chronic kidney disease[J]. The Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2019, 35(11): 1186-1188. [25] SHAO XM, YE HM, QIU XS.Practice of Neonatology(实用新生儿学)[M]. 4th ed.Beijing: People's Medical Publishing House, 2016: 633. [26] Pediatrics Group of Microecology Branch of Chinese Preventive Medicine Association. Evidence-based guidelines to the clinical application of probiotics in pediatrics[J]. Chinese Journal of Practical Pediatrics(中国实用儿科杂志), 2017, 32(32): 81-90. |